knowledge -WSS

knowledge

author：explore 2025-09-27 10:04:33 - browse：5893

A sign of Elevance Health behind some flowers — coverage from STAT — Michael Conroy/AP

These days, the surefire way to get ahead in health insurance is to become a health care provider, and Elevance just upped the ante. It’s joining with private equity to launch a $4 billion primary care company.

Elevance leaders divulged more about the company’s venture with Clayton, Dubilier & Rice on its first quarter earnings call Thursday. The partners announced the new company, yet unnamed, earlier this week, but the release was light on detail. The strategic partnership will house Elevance and CD&R’s doctors, clinics, and the technologies that help those doctors manage their patients.

Health insurers specialize in managing medical costs, and through ventures like this, they apply that expertise to managing patients’ chronic medical conditions. In arrangements like Medicare Advantage, where insurers are paid set amounts for members’ care, they’re incentivized to keep those patients healthy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Federal weight loss drug coverage is 30 years out of date

WSS

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

Bristol Myers buys into radiopharmaceuticals with RayzeBio

Hospitals owned by private equity see complications spike 25%

Virtual care provider acquires bankrupt Pear's prescription apps

Feng Zhang, Grail founder join forces on new gene editing startup

Drinking less cuts risk of oral cavity, esophageal cancer: Report

explore

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

hotspot

Medicare details structure of new drug price negotiation program

Antibiotic resistance and the global rise in human conflict

At least 13 dead in Texas as scorching temps continue

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Editas, Vertex strike deal on CRISPR

Wildfire smoke exposes gaps in outdoor worker protections

3 trends to watch in health tech's hiring outlook for 2024

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

hotspot

Morgan Health, with ambitious aims, wants you to know it’s still here

Drinking less cuts risk of oral cavity, esophageal cancer: Report

UCB departs biotech trade group BIO

The biotech scorecard for Q1: 17 stock

U.K. sequencing study surfaces new findings about tumor DNA

Medicare drug price negotiation hasn't dried up venture capital

focus

focus

hotspot

explore